In summary, the absence of C5aR1 (either by genetic ablation or by pharmacological inhibition) partially averts the excessive microglial synaptic pruning and presynaptic loss in two mouse models of AD and prevents LTP deficits, consistent with a significant role for C5a‐C5aR1 signaling in these pathological events. This evidence concerns the gene C5 and Alzheimer disease.